Severe persistent pulmonary hypertension of the newborn in a setting where limited resources exclude the use of inhaled nitric oxide: successful treatment with sildenafil-Reference-Cited by-同舟云学术

Severe persistent pulmonary hypertension of the newborn in a setting where limited resources exclude the use of inhaled nitric oxide: successful treatment with sildenafil

Published:2005-07-13 Issue:10 Volume:164 Page:626-629
ISSN:0340-6199
Container-title:European Journal of Pediatrics
language:en
Short-container-title:Eur J Pediatr

Author:

Juliana Amadu E.,Abbad Filomena C. B.

Publisher

Springer Science and Business Media LLC

Subject

Pediatrics, Perinatology and Child Health

Link

http://link.springer.com/content/pdf/10.1007/s00431-005-1724-x.pdf

Reference19 articles.

1. American Academy of Pediatrics. Committee on Fetus and Newborn (2000) Use of inhaled nitric oxide. Pediatrics 106: 344–345

2. Archer SL, Huang JM, Hampl V, Nelson DP, Shultz PJ, Weir EK (1994) Nitric oxide and c-GMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by c-GMP-dependent protein kinase. Proc Natl Acad Sci U S A 9116: 7583–7587

3. Clark RH, Kueser TJ, Walker MW, Southgate WM, Huckaby JL, Perez JA, Roy BJ, Keszler M, Kinsella JP (2000) Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N Engl J Med 342: 469–474

4. Clark RH, Huckaby JL, Kueser TJ, Walker MW, Southgate WM, Perez JA, Roy BJ, Keszler M (2003) Low-dose nitric oxide therapy for persistent pulmonary hypertension: 1-year follow-up. J Perinatol 23: 300–303

5. Davidson D, Barefield ES, Kattwinkel J, Dudell G, Damask M, Straube R, Rhines J, Chang CT (1998) Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-Masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group. Pediatrics101: 325–334

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the efficacy of inhaled versus infused milrinone in the management of persistent pulmonary hypertension of the newborn in resource‐limited settings: A randomized clinical trial;Pediatric Pulmonology;2023-05-03

2. Clinical Efficacy and Safety of Different Doses of Sildenafil in the Treatment of Persistent Pulmonary Hypertension of the Newborn: A Network Meta-analysis;Frontiers in Pharmacology;2021-09-24

3. Oral drugs used to treat persistent pulmonary hypertension of the newborn;Expert Review of Clinical Pharmacology;2020-12-01

4. Efficacy of Milrinone Plus Sildenafil in the Treatment of Neonates with Persistent Pulmonary Hypertension in Resource-Limited Settings: Results of a Randomized, Double-Blind Trial;Pediatric Drugs;2020-08-28

5. Pharmacokinetics of sildenafil in children with pulmonary arterial hypertension;World Journal of Pediatrics;2017-08-08